SLC6A3 and supranuclear palsy, progressive, 1: At baseline, the mean (left and right averaged) DAT uptake was significantly higher in HC compared to patients, P < 0.001; however there was no significant difference in DAT uptake between patient groups, that is, PD, MSA, and PSP.